Your search returned 2 results.

Results
	1.	Preclinical safety and pharmacokinetic profile of 3K3A-APC, a novel, modified activated protein C for ischemic stroke. [electronic resource] by Williams, Patricia D Zlokovic, Berislav V Griffin, John H Pryor, Kent E Davis, Thomas P Producer: 20130326 In: Current pharmaceutical design vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Final Results of the RHAPSODY Trial: A Multi-Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A-APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke. [electronic resource] by Lyden, Patrick Pryor, Kent E Coffey, Christopher S Cudkowicz, Merit Conwit, Robin Jadhav, Ashutosh Sawyer, Robert N Claassen, Jan Adeoye, Opeolu Song, Shlee Hannon, Peter Rost, Natalia S Hinduja, Archana Torbey, Michel Lee, Jin-Moo Benesch, Curtis Rippee, Michael Rymer, Marilyn Froehler, Michael T Clarke Haley, E Johnson, Mark Yankey, Jon Magee, Kim Qidwai, Julie Levy, Howard Mark Haacke, E Fawaz, Miller Davis, Thomas P Toga, Arthur W Griffin, John H Zlokovic, Berislav V Producer: 20191125 In: Annals of neurology vol. 85 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search